i2O Therapeutics

Business Data, Corporate Office and Headquarter Address

About

i2O Therapeutics is Drug Delivery in United States that focus on protein-based therapies business. Founded in 2019. They cover business area such as developer, oral formulation, oral peptide, protein-base therapy, permeation, user, intake peptide.

Business Type

Drug Delivery

Country

United States

Founded

2019
( 5 years old in 2024 )

Company Focus

Protein-based Therapies

Website

-

Corporate Office and Headquarter Office address:

127 Western Avenue
Allston
Boston, MA 02134
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developeroral formulationoral peptideprotein-base therapypermeationuserintake peptide

* We use standard office opening hours in near i2O Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

i2O Therapeutics Frequently Asked Questions

What or who is i2O Therapeutics?

I2O Therapeutics is Drug Delivery business from United States that founded in 2019 (5 years old in 2024), i2O Therapeutics business is focusing on Protein-based Therapies.

Where is i2O Therapeutics headquarter and corporate office address?

i2O Therapeutics headquarter office and corporate office address is located in 127 Western Avenue Allston Boston, MA 02134 United States.

Where is i2O Therapeutics country origins?

i2O Therapeutics was founded in United States.

What is Protein-based Therapies business focus on?

In 2024, i2O Therapeutics is currently focus on protein-based therapies sector.

Protein-based Therapies Business Interest from Google Trend

Above is snippet of Google Trends for "protein-based therapies" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with i2O Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.